Loading clinical trials...
Loading clinical trials...
Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Comparison to Consolidation Therapy Based Venetoclax for Elderly Patients With Acute Myeloid Leukemia After First CR
Conditions
Interventions
Venetoclax
Allogeneic transplant
Locations
1
China
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Start Date
July 17, 2024
Primary Completion Date
December 30, 2027
Completion Date
February 28, 2028
Last Updated
August 26, 2024
NCT06285890
NCT06220162
NCT04065399
NCT04628026
NCT06484062
NCT06994676
Lead Sponsor
He Huang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions